Ervebo
Ervebo is a medicine authorised by Swissmedic under authorisation number 68358. The authorisation holder is MSD Merck Sharp & Dohme AG. The medicinal product code is Vaccines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 November 2021 and the authorisation is valid without a time limit. ATC code J07BX02 places the medicine in the group Vaccines.
| Authorisation number | 68358 |
|---|---|
| Name | Ervebo |
| Full name | Ervebo, Injektionslösung |
| Authorisation holder | MSD Merck Sharp & Dohme AG |
| Medicinal product code | Vaccines |
| Dispensing category | B · Prescription only |
| ATC code | J07BX02 |
| First authorisation | 10 November 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ervebo, Injektionslösung | B | 10 November 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Durchstechflasche(n) | J07BX02 | 08.08. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Ervebo authorised in Switzerland?
Yes. Ervebo is authorised by Swissmedic under authorisation number 68358, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ervebo have?
Ervebo is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ervebo?
The authorisation holder is MSD Merck Sharp & Dohme AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.